BRAF mutation predicts sensitivity to MEK inhibition
David B. Solit(Memorial Sloan Kettering Cancer Center), Neal Rosen(Memorial Sloan Kettering Cancer Center), Jose Lobo(Memorial Sloan Kettering Cancer Center), Judith S. Sebolt–Leopold(Pfizer (United States)), Andrea Basso(Memorial Sloan Kettering Cancer Center), Levi A. Garraway(Broad Institute), William R. Sellers(Broad Institute), Christine A. Pratilas(Johns Hopkins University), Iman Osman(New York University), Yuhong She(Memorial Sloan Kettering Cancer Center), Ayana Sawai(Memorial Sloan Kettering Cancer Center), Gad Getz(Broad Institute), Qing Ye(Fujian Medical University), Todd R. Golub(Broad Institute)
Cited by 1,326
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k